Global Health Limited
MEDANTA · General/Diversified · NSE
₹1,095
Current Market Price
Fair Value (DCF)
₹391
Margin of Safety
-64.3%
Updated 18h ago
YieldIQ Score
53/100
Piotroski F-Score
7/9
Economic Moat
Moderate
Confidence
49%
ROE
14.2%
Debt/Equity
0.00
WACC
12.8%
Market Cap
₹0.29 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
17.1%
Return on capital employed
EV / EBITDA
31.4×
Enterprise multiple
Debt / EBITDA
1.0×
Leverage vs earnings
Interest Coverage
11.1×
EBIT covers interest
Current Ratio
2.48×
Short-term liquidity
Asset Turnover
0.76×
Revenue per ₹ of assets
Revenue CAGR (3Y)
15.3%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,094.7
Bear case
₹241.62
MoS -353.1%
Base case
₹390.87
MoS -180.1%
Bull case
₹485.13
MoS -125.7%
Ratio Trends
MEDANTA · last 4 annual periods
ROE
14.2%
ROCE
22.0%
Operating Margin
—
Debt / Equity
0.21×
PE
43.4×
EV / EBITDA
19.9×
Historical Financials
MEDANTA · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹2167 Cr | ₹2694 Cr | ₹3275 Cr | ₹3637 Cr | +18.8% |
| EBITDA | ₹490 Cr | ₹677 Cr | ₹872 Cr | ₹905 Cr | +22.7% |
| EBIT | — | ₹527 Cr | ₹701 Cr | — | +10.0% |
| PAT | ₹196 Cr | ₹326 Cr | ₹478 Cr | ₹481 Cr | +34.9% |
| EPS (diluted) | — | ₹12.57 | ₹17.80 | — | +12.3% |
| CFO | ₹311 Cr | ₹645 Cr | ₹612 Cr | ₹624 Cr | +26.1% |
| CapEx | ₹-274 Cr | — | — | ₹-648 Cr | — |
| FCF | ₹36.8 Cr | — | — | ₹-24.2 Cr | — |
| Total Assets | ₹3146 Cr | ₹4116 Cr | ₹4304 Cr | ₹4766 Cr | +14.9% |
| Total Debt | ₹1109 Cr | ₹105 Cr | ₹136 Cr | ₹718 Cr | -13.5% |
| Shareholders' Equity | ₹1616 Cr | ₹2428 Cr | ₹2906 Cr | ₹3388 Cr | +28.0% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
MEDANTA vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| KIMS Krishna Institute of Medical Sciences Limited | -57.2% | 50 | Data Limited | 15.9% | — |
| ASTERDM Aster DM Healthcare Limited | -74.5% | 48 | Data Limited | 147.3% | — |
| NH Narayana Hrudayalaya Ltd. | -47.8% | 47 | Data Limited | 21.8% | — |
| FORTIS Fortis Healthcare Limited | -47.8% | 58 | Above Fair Value | 8.4% | — |
| MAXHEALTH Max Healthcare Institute Limited | -48.7% | 50 | Above Fair Value | 11.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
1 ex-dividend event on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹0.50/sh
Last payout
2025-08-22
₹0.50
Peak payout
₹0.50
Trailing yield
0.05%
Amounts parsed from NSE subject lines; percent-of-face-value declarations are not converted and shown as missing.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Global Health Limited (MEDANTA.NS) trades at 1094.70 vs a model fair value of 390.87, a gap of -64.3%. Piotroski F-score: 7/9. Moat label...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of MEDANTA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for MEDANTA →
Compare
Head-to-head with peers
Compare MEDANTA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse MEDANTANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.